Medicine and Dentistry
Prostate Cancer
84%
Neoplasm
83%
Prostatectomy
73%
Partial Nephrectomy
71%
Recurrent Disease
63%
Bladder
61%
Disease
57%
Kidney Tumour
56%
Cystectomy
56%
Nephrectomy
51%
Transitional Cell Carcinoma
51%
Clear Cell Renal Cell Carcinoma
50%
Biopsy
46%
Ureter Obstruction
44%
Ex Vivo
44%
Surgery
43%
Magnetic Resonance Imaging
40%
Cancer
40%
Prostate Biopsy
39%
Blood Transfusion
37%
Surgical Margin
36%
Robot-Assisted Prostatectomy
35%
Malignant Neoplasm
34%
Muscle Invasive Bladder Cancer
33%
Endometriosis
33%
Bladder Cancer
32%
Prostate Specific Antigen
31%
Surgeon
31%
Neoadjuvant Chemotherapy
29%
Disease Specific Survival
28%
Pelvis
28%
Urologist
27%
Transurethral Resection
27%
Prostate Specific Membrane Antigen
27%
Biochemical Recurrence
27%
Metastatic Carcinoma
27%
Symptom
27%
Postoperative Complication
26%
Positron Emission Tomography-Computed Tomography
26%
Computer Assisted Tomography
26%
Operation Duration
24%
Overall Survival
24%
Cancer Specific Survival
23%
Urinary System
22%
Radical Nephrectomy
22%
Urologic Oncology
22%
Lymphocyte
22%
Continence
22%
Hypofractionated Radiotherapy
22%
Angiomyolipoma
22%
Keyphrases
Radical Prostatectomy
100%
Prostate-specific Antigen
78%
Prostate Cancer
68%
Renal Cell Carcinoma
61%
Kidney
58%
Partial Nephrectomy
51%
Prostate
51%
Radical Cystectomy
50%
Human Kidney
47%
Upper Tract Urothelial Carcinoma
46%
Malignancy
45%
Tumor
41%
Nephrectomy
41%
Bladder
40%
Cancer Patients
37%
Bladder Cancer
35%
Prostate Biopsy
34%
Renal Mass
34%
Laparoscopic Partial Nephrectomy
34%
Malignant Ureteric Obstruction
33%
Perioperative Blood Transfusion
33%
Muscle-invasive Bladder Cancer
32%
Cancer-specific Survival
31%
Risk Factors
30%
Urologists
29%
Disease-specific Survival
28%
Biochemical Failure
27%
Treatment Outcome
27%
Positive Surgical Margin
27%
Local Recurrence
26%
Histology
26%
Neoadjuvant Chemotherapy
26%
Nomogram
25%
Oncological Outcomes
25%
Systematic Biopsy
25%
Robot-assisted Radical Prostatectomy
24%
Positron Emission Tomography-computed Tomography (PET-CT)
24%
Endoscopic Management
23%
Ureter
23%
Overall Survival
22%
Radical Nephrectomy
22%
Bone Scan
22%
Selective Arterial Embolization
22%
Urologic Oncology
22%
Tandem Ureteral Stent
22%
Renal Angiomyolipoma
22%
Deep Infiltrating Endometriosis
22%
Bladder Endometriosis
22%
Laparoscopic Surgical Robot
22%
Autonomous Cortisol Secretion
22%